Tradestie Institutional Equity Comparison Engine

GNPX vs HOTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HOTH Overall Edge

HOTH Captures Institutional Edge (2โ€“0 Pillars ยท 4โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Hoth Therapeutics, Inc. Common Stock (HOTH) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus HOTH at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HOTH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNPX N/M vs HOTH N/M Fwd P/E
Growth & Margin Winner HOTH
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner HOTH
1Y -56.6% vs +59.2% ยท 52W Pos 11% vs 54%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
HOTH NASDAQ
Hoth Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.36
+92.01% 1D
Market Cap $22.6M
1M Return +74.36%
1Y Return +59.25%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNPX -56.59% HOTH +59.25% Spread: +95.02 pp (HOTH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNPX TTM Op. Margin: 0.0% HOTH TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs HOTH. Trailing 12-month operating profitability (GNPX 0.0% vs HOTH 0.0%) and valuation multiples (GNPX N/M vs HOTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNPX (1) vs HOTH (4)
Institutional Metric GNPX HOTH Criterion Row Winner
Market Capitalization Scale $2.2M $22.6M Larger Scale HOTH
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -233.7% -191.4% Higher ROE HOTH
52-Week Range Position Momentum 11% ($0โ€“$10) 54% ($0โ€“$2) Stronger Trend HOTH
Beta / 30D Volatility Risk Regime -4.68ฮฒ ยท 96% Vol 1.92ฮฒ ยท 324% Vol Lower Realized Risk GNPX
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 51.1 / 100 (HOLD) Higher Composite HOTH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNPX vs HOTH Buy Guide
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HOTH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HOTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNPX nor HOTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.